Astellas Pharma Inc (ALPMY)
9.49
-0.04
(-0.42%)
USD |
OTCM |
Apr 23, 16:00
Astellas Pharma Market Cap: 17.02B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 17.02B |
| April 22, 2024 | 17.09B |
| April 19, 2024 | 17.03B |
| April 18, 2024 | 16.98B |
| April 17, 2024 | 16.96B |
| April 16, 2024 | 16.75B |
| April 15, 2024 | 16.62B |
| April 12, 2024 | 17.12B |
| April 11, 2024 | 18.45B |
| April 10, 2024 | 18.35B |
| April 09, 2024 | 18.77B |
| April 08, 2024 | 18.86B |
| April 05, 2024 | 19.01B |
| April 04, 2024 | 18.97B |
| April 03, 2024 | 19.17B |
| April 02, 2024 | 19.35B |
| April 01, 2024 | 19.31B |
| March 28, 2024 | 19.27B |
| March 27, 2024 | 19.62B |
| March 26, 2024 | 19.83B |
| March 25, 2024 | 19.54B |
| March 22, 2024 | 19.76B |
| March 21, 2024 | 19.85B |
| March 20, 2024 | 19.63B |
| March 19, 2024 | 19.51B |
| Date | Value |
|---|---|
| March 18, 2024 | 19.45B |
| March 15, 2024 | 19.41B |
| March 14, 2024 | 19.13B |
| March 13, 2024 | 19.17B |
| March 12, 2024 | 19.29B |
| March 11, 2024 | 19.53B |
| March 08, 2024 | 19.04B |
| March 07, 2024 | 19.27B |
| March 06, 2024 | 19.38B |
| March 05, 2024 | 19.36B |
| March 04, 2024 | 19.87B |
| March 01, 2024 | 19.99B |
| February 29, 2024 | 19.60B |
| February 28, 2024 | 19.69B |
| February 27, 2024 | 19.70B |
| February 26, 2024 | 19.78B |
| February 23, 2024 | 19.70B |
| February 22, 2024 | 19.65B |
| February 21, 2024 | 19.94B |
| February 20, 2024 | 19.97B |
| February 16, 2024 | 19.90B |
| February 15, 2024 | 19.81B |
| February 14, 2024 | 19.86B |
| February 13, 2024 | 19.53B |
| February 12, 2024 | 19.40B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.62B
Minimum
Apr 15 2024
34.22B
Maximum
Jun 01 2020
27.80B
Average
28.14B
Median
Apr 15 2021
Market Cap Benchmarks
| Takeda Pharmaceutical Co Ltd | 41.98B |
| Nxera Pharma Co Ltd | 869.42M |
| PeptiDream Inc | 1.231B |
| Stemcell Holdings Inc | 1.643M |
| Healios KK | 84.71M |
Market Cap Related Metrics
| PS Ratio | 1.561 |
| Price to Book Value | 1.596 |
| Price to Free Cash Flow | 18.01 |
| Price | 9.49 |
| Earnings Yield | -0.09% |
| Operating PE Ratio | 247.22 |